[go: up one dir, main page]

DE60121293D1 - Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen - Google Patents

Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen

Info

Publication number
DE60121293D1
DE60121293D1 DE60121293T DE60121293T DE60121293D1 DE 60121293 D1 DE60121293 D1 DE 60121293D1 DE 60121293 T DE60121293 T DE 60121293T DE 60121293 T DE60121293 T DE 60121293T DE 60121293 D1 DE60121293 D1 DE 60121293D1
Authority
DE
Germany
Prior art keywords
steroidical
structures
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121293T
Other languages
English (en)
Other versions
DE60121293T2 (de
Inventor
Victor Potter
John Reed
Walter Elger
Gudrun Roddersen
Henrich-Thomas Proske
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterix Ltd
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0000792A external-priority patent/GB0000792D0/en
Priority claimed from GB0002115A external-priority patent/GB0002115D0/en
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of DE60121293D1 publication Critical patent/DE60121293D1/de
Application granted granted Critical
Publication of DE60121293T2 publication Critical patent/DE60121293T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Confectionery (AREA)
DE60121293T 2000-01-14 2001-01-11 Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen Expired - Lifetime DE60121293T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0000792A GB0000792D0 (en) 2000-01-14 2000-01-14 Composition
GB0000792 2000-01-14
GB0002115A GB0002115D0 (en) 2000-01-28 2000-01-28 Composition
GB0002115 2000-01-28
US21873000P 2000-07-17 2000-07-17
US218730P 2000-07-17
PCT/GB2001/000094 WO2001051055A2 (en) 2000-01-14 2001-01-11 Pharmaceutical compositions containing steroidal structures and uses thereof

Publications (2)

Publication Number Publication Date
DE60121293D1 true DE60121293D1 (de) 2006-08-17
DE60121293T2 DE60121293T2 (de) 2007-06-28

Family

ID=27255470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121293T Expired - Lifetime DE60121293T2 (de) 2000-01-14 2001-01-11 Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen

Country Status (26)

Country Link
EP (1) EP1248626B1 (de)
JP (1) JP2003519658A (de)
KR (1) KR20020087930A (de)
CN (1) CN1404394A (de)
AR (1) AR028196A1 (de)
AT (1) ATE332140T1 (de)
AU (1) AU2533101A (de)
BG (1) BG106914A (de)
BR (1) BR0107630A (de)
CA (1) CA2396098A1 (de)
CO (1) CO5280199A1 (de)
CZ (1) CZ20022282A3 (de)
DE (1) DE60121293T2 (de)
EE (1) EE200200391A (de)
ES (1) ES2267707T3 (de)
HR (1) HRP20020665A2 (de)
HU (1) HUP0300887A2 (de)
IL (1) IL150471A0 (de)
MX (1) MXPA01000464A (de)
NO (1) NO20023392L (de)
PE (1) PE20011121A1 (de)
PL (1) PL357020A1 (de)
SK (1) SK10022002A3 (de)
TR (1) TR200100070A3 (de)
UY (1) UY26530A1 (de)
WO (1) WO2001051055A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1358882A1 (de) * 2002-04-30 2003-11-05 Schering Aktiengesellschaft Verwendung von Prodrogue von Estriol sulfamate zur Behandlung von autoimmunischen Erkrankungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
KR200449618Y1 (ko) * 2008-01-16 2010-07-23 주식회사 코비스 스포츠 그린보수기
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
JP7154616B2 (ja) * 2017-06-01 2022-10-18 ネクシオン バイオテック カンパニー リミテッド 骨関連疾患の予防または治療のための薬学組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen

Also Published As

Publication number Publication date
IL150471A0 (en) 2002-12-01
ATE332140T1 (de) 2006-07-15
AR028196A1 (es) 2003-04-30
CA2396098A1 (en) 2001-07-19
CZ20022282A3 (cs) 2002-11-13
MXPA01000464A (es) 2003-07-21
CN1404394A (zh) 2003-03-19
AU2533101A (en) 2001-07-24
EE200200391A (et) 2003-12-15
WO2001051055A2 (en) 2001-07-19
NO20023392D0 (no) 2002-07-12
CO5280199A1 (es) 2003-05-30
KR20020087930A (ko) 2002-11-23
PL357020A1 (en) 2004-07-12
ES2267707T3 (es) 2007-03-16
BR0107630A (pt) 2002-10-08
HRP20020665A2 (en) 2004-12-31
NO20023392L (no) 2002-09-16
SK10022002A3 (sk) 2002-12-03
EP1248626A2 (de) 2002-10-16
EP1248626B1 (de) 2006-07-05
PE20011121A1 (es) 2001-11-05
BG106914A (en) 2003-01-31
UY26530A1 (es) 2001-07-31
TR200100070A2 (tr) 2001-08-21
HUP0300887A2 (hu) 2003-07-28
TR200100070A3 (tr) 2001-08-21
DE60121293T2 (de) 2007-06-28
WO2001051055A3 (en) 2002-03-21
JP2003519658A (ja) 2003-06-24

Similar Documents

Publication Publication Date Title
ATE468324T1 (de) Pharmazeutische zusammensetzung
DE60142890D1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
ATE340158T1 (de) Pyrrolcarboxamide und pyrrolcarbothioamide und deren agrochemische verwendungen
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69812433D1 (de) Anti-estrogene steroide, pharmazeutische zusammensetzungen und verwendungen davon
DE60219051D1 (de) Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
ATE320244T1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE60142340D1 (de) Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
DE60129238D1 (de) Pharmazeutische zusammensetzung
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition